載入...
Effects of chidamide and its combination with decitabine on proliferation and apoptosis of leukemia cell lines
Chidamide, a novel histone deacetylase inhibitor (HDACI), shows anticancer ability against leukemia and solid tumors. Decitabine (5-Aza-2’-deoxycytidine, DAC), an anti-leukemic drug, is effective in treating acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). In our study, we investigat...
Na minha lista:
| 發表在: | Am J Transl Res |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
e-Century Publishing Corporation
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6129529/ https://ncbi.nlm.nih.gov/pubmed/30210693 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|